Cystic Fibrosis Foundation - Neonatal Disorders

Relevant Publications

Cell type-specific expression of angiotensin receptors in the human lung with implications for health, aging, and chronic disease.

Issue Release: 2024

Sex differences persist after treatment with ivacaftor in people with cystic fibrosis.

Issue Release: 2024

A model for oversight of rare disease studies: The 25-year experience of the cystic fibrosis foundation data safety monitoring board.

Issue Release: 2024

Cystic fibrosis foundation position paper: Redefining the cystic fibrosis care team.

Issue Release: 2024

Lung transplant referral considerations for individuals with cystic fibrosis.

Issue Release: 2024

Metabolic specialization drives reduced pathogenicity in Pseudomonas aeruginosa isolates from cystic fibrosis patients.

Issue Release: 2024

A Retrospective, Longitudinal Registry Study on the Long-Term Durability of Ivacaftor Treatment in People with Cystic Fibrosis.

Issue Release: 2024

Response to comment on \"International consensus recommendations for the use of prolonged-infusion β-lactams endorsed by the American College of Clinical Pharmacy (ACCP), the British Society for Antimicrobial Chemotherapy (BSAC), the Cystic Fibrosis Foundation (CFF), the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), the Infectious Diseases Society of American (IDSA), the Society of Critical Care Medicine (SCCM), and the Society of Infectious Diseases Pharmacists\".

Issue Release: 2024

Heterogeneity of CFTR modulator-induced sweat chloride concentrations in people with cystic fibrosis.

Issue Release: 2024

Remote endpoints for clinical trials in cystic fibrosis: Report from the U.S. CF foundation remote endpoints task force.

Issue Release: 2024

Female mice display sex-specific differences in cerebrovascular function and subarachnoid haemorrhage-induced injury.

Issue Release: 2024

A comparison of aminoglycoside antibiotic serum concentrations collected by peripheral veins and peripherally inserted central catheters in adults with cystic fibrosis.

Issue Release: 2024

Cystic fibrosis-related diabetes screening at a large pediatric center.

Issue Release: 2024

Correction: Myeloid Heterogeneity Mediates Acute Exacerbations of Pulmonary Fibrosis.

Issue Release: 2024

The Real-World Effectiveness of Antifungals in People with Cystic Fibrosis and -Positive Cultures.

Issue Release: 2024

Linaclotide Use for the Treatment of Constipation and Gastrointestinal Symptoms in People With Cystic Fibrosis.

Issue Release: 2024

Predictors of frequency of CF care in the US Cystic Fibrosis Foundation Patient Registry.

Issue Release: 2024

Linkage of the CF Foundation Patient Registry with the Scientific Registry of Transplant Recipients database.

Issue Release: 2024

Cystic Fibrosis Foundation Evidence-Based Guideline for the Management of CRMS/CFSPID.

Issue Release: 2024

Clinical outcomes at 9-10 years of age in children born with cystic fibrosis transmembrane conductance regulator related metabolic syndrome.

Issue Release: 2024

How Can Nutrition Labels Help Manage Food Allergies?

What Are the Advantages of OCT in Pediatrics?

What is the Blood Brain Barrier (BBB)?

What is Chlorine?

What is the Role of Pediatricians in Community Health Centers?

How are Research Findings Published?

How to Transition from Breastfeeding to Formula Feeding?

What is Cool Down?

Why Are Coding Manuals Important?

What Treatments Are Available for Impaired Placental Transfer?

Cystic Fibrosis Foundation - Neonatal Disorders

Relevant Publications

Partnered Content Networks

Relevant Topics